Evidence map›Paper›PMID 29422888›Full record

ArticleFrontiers in microbiology2018

Eun-Jeong Yoon, Jung Ok Kim, Dokyun Kim, Hyukmin Lee, Ji Woo Yang, Kwang Jun Lee, Seok Hoon Jeong

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 47 citations in OpenAlex.

  1. Dissemination ofEmerging microbes & infections · 2026
    Article
  2. Article
  3. Genomic analysis of carbapenem-resistantFrontiers in microbiology · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. BioMed research international · 2023
    Article
  11. Article
  12. Article
  13. Genetic Characterization of Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2022
    Article
  14. Article
  15. Association of Carbapenemase-ProducingFrontiers in microbiology · 2022
    Article
  16. Two Distinct Genotypes of KPC-2-ProducingAntibiotics (Basel, Switzerland) · 2021
    Article
  17. Multidrug-resistant mcr-1 gene-positive Klebsiella pneumoniae ST307 causing urinary tract infection in a cat.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2021
    Article
  18. Prevalence and antimicrobial resistance ofJournal of veterinary science · 2021
    Article
  19. Article
  20. Mobile Carbapenemase Genes inFrontiers in microbiology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Eun-Jeong YoonDepartment of Laboratory Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Jung Ok KimDepartment of Laboratory Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Dokyun KimDepartment of Laboratory Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Hyukmin LeeDepartment of Laboratory Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Ji Woo YangCenters for Disease Control and Prevention, National Institute of Health, Cheongju, South Korea.
Kwang Jun LeeCenters for Disease Control and Prevention, National Institute of Health, Cheongju, South Korea.
Seok Hoon JeongDepartment of Laboratory Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Yonsei University · KRKorea Center for Disease Control and Prevention · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Between 2014 and 2015, the

Indexed as

carbapenemase producing Enterobacteriaceaecarbapenem resistanceKlebsiella pneumoniae ST307KPCTn4401

Identifiers

PMID29422888
PMCPMC5788937
OpenAlexW2790600481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.